In addition to AZD8055 and SKI606, we also retested compounds #2180 (TMP195, HDAC inhibitor), #2250 (CHR6494 trifluoroacetate, Haspin inhibitor), #2831 (EPZ015666, Prmt5 inhibitor), #1801 (pyroxamide, HDAC 1 inhibitor), #1803 (MS 275, HDAC 1 and 3 inhibitor), and #2008 (Tenovin 1, SIRT 1 & 2 inhibitor) that also showed some effect in the primary CIN screen. This evidence concerns the gene PRMT5 and cervical squamous intraepithelial neoplasia.